Skip to main content

Table 7 Comparison of drug to avoid based on match between drug’s side effect profile and patients’ rankinga

From: Patient preferences of chemotherapy treatment options and tolerance of chemotherapy side effects in advanced stage lung cancer

Drug to avoid FIRST Interview
n = 167b (%)
LAST Interview
n = 166b (%)
Drug A 56 (33.5) 42 (25.3)
Drug B 71 (42.5) 82 (49.4)
Drug C 26 (15.6) 25 (15.1)
Drug D 14 (8.4) 17 (10.2)
  1. aexcludes those who did not complete at least 2 interviews
  2. bexcludes those who did not complete the Ranking Exercise section